TP53 and breast cancer: In mouse fibroblasts and breast cancer cells, amifostine and its metabolite WR-1065 have been shown to activate p53 protein, to induce the expression of the cyclin-dependent kinase inhibitor p21, and to arrest cells at the G1/S transition via a p53-dependent pathway (North et al, 2000).